Cargando…
The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139039/ https://www.ncbi.nlm.nih.gov/pubmed/32274079 http://dx.doi.org/10.21037/jtd.2019.12.80 |
| _version_ | 1783518677039054848 |
|---|---|
| author | Gil, Hyun-Il Um, Sang-Won |
| author_facet | Gil, Hyun-Il Um, Sang-Won |
| author_sort | Gil, Hyun-Il |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7139039 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71390392020-04-09 The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer Gil, Hyun-Il Um, Sang-Won J Thorac Dis Editorial AME Publishing Company 2020-03 /pmc/articles/PMC7139039/ /pubmed/32274079 http://dx.doi.org/10.21037/jtd.2019.12.80 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Gil, Hyun-Il Um, Sang-Won The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer |
| title | The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer |
| title_full | The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer |
| title_fullStr | The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer |
| title_full_unstemmed | The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer |
| title_short | The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer |
| title_sort | impact of age and performance status on the efficacy of osimertinib in patients with egfr t790m-positive non-small cell lung cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139039/ https://www.ncbi.nlm.nih.gov/pubmed/32274079 http://dx.doi.org/10.21037/jtd.2019.12.80 |
| work_keys_str_mv | AT gilhyunil theimpactofageandperformancestatusontheefficacyofosimertinibinpatientswithegfrt790mpositivenonsmallcelllungcancer AT umsangwon theimpactofageandperformancestatusontheefficacyofosimertinibinpatientswithegfrt790mpositivenonsmallcelllungcancer AT gilhyunil impactofageandperformancestatusontheefficacyofosimertinibinpatientswithegfrt790mpositivenonsmallcelllungcancer AT umsangwon impactofageandperformancestatusontheefficacyofosimertinibinpatientswithegfrt790mpositivenonsmallcelllungcancer |